Sorcero Generative AI Platform Achieves Breakthrough in Patient Accessibility
Summary
In fact, extensive research conducted in collaboration with UCB, a patient-centric Belgian pharmaceutical company, and Lumanity, a global leader in medical and commercial life sciences services, validated the effectiveness of Sorceros AI-driven PLS solution. "Our partnership with Sorcero allows us to realize the full potential of expert guided AI, directed specifically at accelerating the development and adoption of life-saving therapies," said Michael Parisi, Global Practice Lead, Medical Strategy and Communications, Lumanity. • The Sorcero AI process saved medical writers more than 40% of the time needed to create a PLS abstract and required less effort than manual writing. "We are thrilled to see our platform enabling healthcare innovation, while prioritizing compliance with crucial industry standards like Good Publication Practice guidelines." As Sorcero continues to grow and innovate, the company remains committed to its mission of improving the accessibility and understanding of scientific research, ultimately leading to better-informed patients and more effective treatments.